FSA closes the public list for CBD authorisations

The agency recently published the latest public list which includes 12,000 products – up from 6,000 in March – and said it was grateful for “the help and cooperation of the CBD industry”​.

The FSA’s Director of Policy, Rebecca Subworth, commented that the initial list prompted a number of companies to come forward with new evidence linking large numbers of individual products to existing applications.

As a result, the agency made a final call for evidence to support businesses in achieving compliance for their products.

“We think it is important we get this right, and it is encouraging that so many companies want to get their CBD products on the path to authorisation,” ​she said.

Although the list is now closed, businesses can continue to apply for authorisation of CBD food products through the regulated products process (for Great Britain) or via the European Commission for those wanting to sell products in Northern Ireland.

However, new applications will not be eligible for the public list and should not be put on sale until they have been authorised, according to the agency.

Market regulations

CBD extract acquired novel food status in January 2019. Under novel food regulations, any food or food ingredient with no history of consumption before May 1997 should be evaluated and authorised before they can be sold to the general public.

Authorisation is required to demonstrate products comply with legal, safety and content standards, to protect public health. Products need to be correctly labelled and not considered as being controlled substance.

Be the first to comment

Leave a Reply

Your email address will not be published.


*